Diverse bacteria community inside human gut, some forming kidney stones

Gut Check: Can Your Gut Bacteria Impact Kidney Stone Risk?

"A new study explores the link between gut microbiota and oxalate stone disease, offering insights into prevention and treatment."


The human gut is a bustling ecosystem, home to trillions of bacteria, archaea, fungi, and other microorganisms collectively known as the gut microbiota. This complex community plays a vital role in various aspects of our health, from digestion and immunity to even mental well-being. Recent research has begun to uncover the intricate connections between the gut microbiota and seemingly unrelated conditions, including kidney stone disease.

Kidney stones are hard deposits made of minerals and salts that form inside the kidneys. While several factors contribute to their development, including genetics, diet, and hydration, a growing body of evidence suggests that the gut microbiota may also play a significant role. Specifically, imbalances in the gut microbiota, known as dysbiosis, can affect the levels of certain substances in the body, such as oxalate, which can increase the risk of kidney stone formation.

A new study published in Scientific Reports delves into the relationship between gut microbiota composition and oxalate stone disease. The researchers investigated the gut microbiota of individuals with recurrent oxalate kidney stones and compared it to that of healthy controls. Their findings reveal intriguing differences in the types and abundance of microorganisms present in the guts of these two groups, shedding light on the potential role of the gut microbiota in kidney stone development.

AI Search Multiple angles on this topic

Kidney Function and Health

The kidneys filter blood in structures called nephrons, and the NIDDK reports that they filter about 150 quarts of blood in a single day. Each kidney connects to a ureter, which carries urine to the bladder, while the kidneys help regulate body-fluid volume, osmolality, acid-base balance, and electrolytes. Common kidney conditions include kidney disease, kidney infections, and kidney cysts.

Recognizing Kidney Disease

A standard starting point is to recognize common signs and symptoms that may indicate kidney disease. The National Kidney Foundation presents these warning signs as information that can help people understand what symptoms may mean for their health. This source does not establish how well symptom recognition identifies gut-related kidney stone risk, so symptoms alone should not be treated as a complete assessment.

A Developing Field

The connection between gut bacteria and kidney stone risk is an evolving area of health research. Its historical milestones and foundational discoveries cannot be established from the supplied source material. Any account of this history would therefore require additional, topic-specific evidence.

Dysbiosis and Oxalate Stone Disease: What's the Connection?

Diverse bacteria community inside human gut, some forming kidney stones

The study's key finding is that individuals with recurrent oxalate kidney stones exhibit a distinct pattern of gut dysbiosis compared to healthy individuals. This dysbiosis involves changes in the abundance and diversity of various microorganisms, including bacteria, archaea, and fungi. Specifically, the researchers observed a decrease in beneficial bacteria, such as Oxalobacter formigenes, which helps break down oxalate in the gut, and an increase in potentially harmful bacteria.

Here are some of the key changes the study identified:

  • Reduced Oxalobacter formigenes: This bacterium is a key player in oxalate metabolism. Its presence helps to reduce the amount of oxalate absorbed into the bloodstream, lowering the risk of kidney stone formation.
  • Increased Dysgenic Taxa: The augmentation of trans-domain species diversity has been found to be higher with dysgenic taxa.
  • Decreased Butyrate-Producing Bacteria: Butyrate is a short-chain fatty acid that promotes gut health and reduces inflammation. A decrease in butyrate-producing bacteria may contribute to gut dysbiosis and increase the risk of kidney stone formation.
AI Search Multiple angles on this topic

Evidence Still Emerging

Current research on gut bacteria and kidney stone risk should be interpreted cautiously. The supplied source material does not include a recent study or review that establishes a specific bacterial mechanism, treatment, or level of risk. Strong conclusions about this relationship require direct research evidence.

Limits of Current Claims

Claims that gut bacteria determine kidney stone risk cannot be evaluated from the supplied sources. The material does not provide contradictory studies, failed interventions, or evidence that would confirm or reject a specific microbiome-based explanation. The absence of that evidence makes broad causal conclusions premature.

No Direct Comparison Available

The supplied material does not compare gut bacterial profiles, kidney stone types, patient groups, or prevention strategies. As a result, it does not support ranking one microbiome-related explanation or approach above another. Comparative conclusions would require studies designed to measure those differences.

These changes in the gut microbiota can lead to increased oxalate absorption and excretion in the urine, creating a favorable environment for oxalate stone formation. The researchers also found that individuals with oxalate stones had lower levels of certain beneficial metabolites, such as butyrate, which may further contribute to gut dysbiosis and inflammation.

The Future of Kidney Stone Prevention: Targeting the Gut Microbiota

These findings highlight the potential for targeting the gut microbiota as a novel strategy for preventing and treating oxalate kidney stones. While more research is needed to fully understand the complex interactions between the gut microbiota and kidney stone formation, several interventions may hold promise, including probiotics, prebiotics, and dietary modifications. By promoting a healthy gut microbiota, we may be able to reduce oxalate absorption, improve gut health, and ultimately lower the risk of kidney stone disease. It is essential to consult with healthcare provider before making significant changes to your diet or starting any new supplements.

AI Search Multiple angles on this topic

A Cautious Interpretation

The supplied evidence supports the importance of kidney function but does not establish how gut bacteria affect kidney stone risk. A responsible synthesis should distinguish established kidney biology from early or unverified microbiome hypotheses. Expert interpretation would require direct clinical and microbiome research.

Questions for Future Research

Future work may clarify whether particular gut bacteria are associated with kidney stone formation or prevention. The supplied sources do not identify validated bacterial targets, diagnostic tests, or microbiome treatments. Those possibilities remain research questions rather than established clinical recommendations.

Unrelated Source Context

The supplied sources for this subsection describe xHamster, an adult-content platform, its categories, and its published video listings. They do not address gut bacteria, kidney stones, kidney health, or related systemic challenges. Consequently, they provide no evidence for a health-related broader-context analysis.

Individual Impact Requires Evidence

Kidney stone risk can have real consequences for individuals, but the supplied sources do not describe patients, lived experiences, treatment decisions, or outcomes involving gut bacteria. They therefore cannot support a specific account of how microbiome-related kidney stone claims affect people. Patient-centered conclusions require direct clinical evidence.

The weight of this case-control evidence

Observational study (level 4 of 8)

The study compared people with recurrent oxalate kidney stone disease with healthy controls and examined gut microbial composition and functional diversity. This observational comparison can identify differences between groups, but it cannot establish whether those differences contribute to stone disease or result from it.[1] [2]

The authors note that the participant group was small, which makes the findings less conclusive than evidence from a larger study would be.[1] [2]

What the reported percentages describe

  • 88.13 % of bacteria enriched in KSDOxalate-metabolizing bacteria made up 88.13% of the bacteria enriched in the kidney stone disease group; this is a share of the enriched bacteria, not a percentage of participants or a measure of stone risk.[1] [2]
  • 118 of 785; 20.08Among 785 detected OTUs, 118 were retained in kidney stone disease subjects colonized by Oxalobacter, reported as 20.08% of the healthy-group flora. This describes overlap with the healthy group, not the proportion of patients carrying the bacterium.[1]

Where the study's conclusions are bounded

  • The authors could not determine whether hyperoxaluria favored enrichment of oxalate-using bacteria or whether gut disturbance contributed to hyperoxaluria.[1]

A comparison of recurrent oxalate stone disease and healthy controls

Study designObservational study[2]
PopulationRecurrent oxalate kidney stone disease subjects and healthy controls[2]
ComparisonHealthy subjects (HLT)[2]
Main outcomeGut microbiota trans-domain composition and functional oxalate-metabolizing and butyrate-producing diversity[2]
Effect sizeOxalate metabolizing bacteria accounted for 88.13% among those enriched in KSD[2]
p-valuep < 0.001[2]
StatusA correction has been published[2]
Times cited25[2]

How this study fits with later microbiome research

The review summarized reports of altered real or predicted microbial functional capacity across studies of adults with kidney disease and stones. It also noted that butyrate-producing species found in controls were absent from stone-former samples in later targeted-gene work.[3]

Questions the microbial comparison leaves open

  • Can the association between Oxalobacter colonization and other microbial functions be separated from the effects of the wider gut community?[1] [2]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1038/s41598-018-33773-5, Alternate LINK

Title: Functional Eubacteria Species Along With Trans-Domain Gut Inhabitants Favour Dysgenic Diversity In Oxalate Stone Disease

Subject: Multidisciplinary

Journal: Scientific Reports

Publisher: Springer Science and Business Media LLC

Authors: Mangesh V. Suryavanshi, Shrikant S. Bhute, Rahul P. Gune, Yogesh S. Shouche

Published: 2018-11-09

Everything You Need To Know

1

How does the gut microbiota relate to kidney stone development?

The gut microbiota, a complex community of microorganisms in the gut, can influence the risk of kidney stone formation. Imbalances in the gut microbiota, known as dysbiosis, can affect the levels of substances like oxalate in the body, increasing the risk of kidney stones. Specifically, a decrease in beneficial bacteria like *Oxalobacter formigenes* and a decrease in butyrate-producing bacteria can lead to increased oxalate absorption and excretion, promoting stone formation. The study also found the augmentation of trans-domain species diversity to be higher with dysgenic taxa.

2

What is *Oxalobacter formigenes*, and why is it important in the context of kidney stones?

*Oxalobacter formigenes* is a bacterium in the gut that plays a crucial role in oxalate metabolism. It helps break down oxalate, reducing the amount absorbed into the bloodstream. Lower levels of *Oxalobacter formigenes* can lead to increased oxalate absorption and excretion in the urine, creating an environment favorable for oxalate stone formation. Its absence or reduction can significantly impact an individual's susceptibility to oxalate kidney stones.

3

Besides *Oxalobacter formigenes*, what other changes in the gut microbiota are associated with oxalate kidney stones?

Besides a reduction in *Oxalobacter formigenes*, individuals with oxalate kidney stones also exhibit a decrease in butyrate-producing bacteria and an increase of dysgenic taxa. Butyrate is a short-chain fatty acid that promotes gut health and reduces inflammation, so a decrease can contribute to gut dysbiosis. The augmentation of trans-domain species diversity has been found to be higher with dysgenic taxa, contributing to gut dysbiosis and potentially increased inflammation, increasing the risk of oxalate kidney stone development.

4

Can interventions targeting the gut microbiota prevent kidney stones, and what types of interventions are being considered?

Targeting the gut microbiota holds promise as a novel strategy for preventing and treating oxalate kidney stones. Interventions being considered include the use of probiotics to introduce beneficial bacteria, prebiotics to promote the growth of existing beneficial bacteria, and dietary modifications to support a healthy gut environment. These approaches aim to reduce oxalate absorption and improve overall gut health, potentially lowering the risk of kidney stone disease. However, it's important to consult with a healthcare provider before making significant changes to your diet or starting any new supplements.

5

How does gut dysbiosis specifically lead to an increased risk of oxalate kidney stones?

Gut dysbiosis leads to an increased risk of oxalate kidney stones through several mechanisms. Firstly, a reduction in beneficial bacteria such as *Oxalobacter formigenes* impairs the breakdown of oxalate in the gut, resulting in increased oxalate absorption into the bloodstream. Simultaneously, a decrease in butyrate-producing bacteria compromises gut health and potentially increases gut inflammation. Finally, augmentation of trans-domain species diversity has been found to be higher with dysgenic taxa. The combined effect of these imbalances results in higher levels of oxalate in the urine, creating an environment that is more conducive to the formation of oxalate kidney stones.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.